This is a study to test the dosing and safety of the drug AB248 for people who have an advanced melanoma tumors and who have previously received systemic therapy.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Frances Collichio
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Melanoma)
23-3129
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
